The effect of mitomycin C on Molteno implant surgery: A 1-year randomized, masked, prospective study

Journal of Glaucoma

Volumn 7, Issue 4, 1998, Pages 240-246

  Cantor, L ^a   Burgoyne, J ^a   Sanders, S ^b   Bhavnani, V ^c   Hoop, J ^a   Brizendine, E ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c NONE

Author keywords

High risk glaucoma surgery; Mitomycin C; Molteno implant

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIMETABOLITE; MITOMYCIN C;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLAUCOMA; HUMAN; IMPLANT; INTRAOCULAR PRESSURE; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHUNTING; STATISTICAL ANALYSIS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; GLAUCOMA; HUMANS; INCIDENCE; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MITOMYCIN; MOLTENO IMPLANTS; NUCLEIC ACID SYNTHESIS INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 0032468641     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rosenberg LF, Krupin T. Implants in glaucoma surgery. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. St. Louis: Mosby, 1996;1783-1807.
2. Classen L, Divela T, Tarkkenan A. Histopathologic and immunohistochemical analysis of the filtration bleb after unsuccessful glaucoma seton implantation. Am J Ophthalmol 1996;122:205-212.
3. Molteno ACB, Straughan JL, Ancker E. Long tube implants in the management of glaucoma. S Afr Med J 1976;50:1062-1066.
4. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988;95:813-821.
5. Khaw P, Sherwood MB, MacKay SA, Rossi MJ, Schulz G. Five-minute treatment with fluorouracil, floxuridine, and mitomycin have long term effects on human tenon's capsule fibroblasts. Arch Ophthalmol 1992;110:1150-1154.
6. Chen CW. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin-C. Transactions of the Asia-Pacific Academy of Ophthalmology 1983;9:172-177.
7. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology 1991;98:317-321.
8. Mietz H, Arnold G, Kirchhof B, Diestelhorst M, Krieglstein GK. Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C. Graefes Arch Clin Exp Ophthalmol 1996; 234:364-368.
9. Perkins TW, Cardakli UF, Eisele JR, et al. Adjunctive mitomycin C in Molteno implant surgery. Ophthalmology 1995;102:91-97.
10. Susanna R, Nicolela MT, Takahashi WY. Mitomycin C as adjunctive therapy with glaucoma implant surgery. Ophthalmic Surgery 1994;25:458-462.
11. Diestelhorst M, Krieglstein GK. Effect of mitomycin-C on aqueous humor flow after trabeculectomy. Ophthalmologe 1995;92:542-545.
12. Price FW, Willemeyer M. Long-term results of Molteno implant. Ophthalmic Surgery 1995;26:130-135.
13. Heuer DK, Lloyd MA, Abrams DA, et al. Which is better? one or two? Ophthalmology 1992;99:1512-1519.
14. Mills RP, Reynolds A, Emond MJ, et al. Long-term survival of Molteno glaucoma drainage devices. Ophthalmology 1996;103: 299-305.
15. Prata JA Jr, Minckler DS, Mermoud A, Baerveldt G. Effects of intraoperative mitomycin-C on the function of Baerveldt glaucoma drainage implants in rabbits. J Glaucoma 1996;5:29-38.
16. Yamamato T, Varani J, Soong HK, Lichter PR. Effects of 5-fluorouracil and mitomycin C on cultured rabbit subconjunctival fibroblasts. Ophthalmology 1990;97:1204-1210.
17. Krupin TH, Birt CM, Shin DH, et al. Long term outcome of Molteno device implantation with and without adjunctive mitomycin C use (abstract). Invest Ophthalmol Vis Sci 1994;35(suppl):3049.
18. Law SK, Kalenak JW, Connor TB, et al. Retinal complications after aqueous shunt surgical procedures for glaucoma. Arch Ophthalmol 1995;114:1473-1480.
19. Costa VP, Comegno PEC, Vaconcelos JPC, Malta RFS, Jose NK. Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma. J Glaucoma 1996;5:193-199.
20. Skuta GL, Beeson CC, Higgenbotham EJ, et al. Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1992;99:438-444.
21. Kitazawa Y, Kazuhide K, Matsushita H, Minobe M. Trabeculectomy with mitomycin. Arch Ophthalmol 1991;109:1693-1698.
22. Smith MF, Doyle W, Nguyen Q, Sherwood MB. Results of intraoperative 5-fluorouracil or lower dose mitomycin-C administration on initial trabeculectomy surgery. J Glaucoma 1997;6:104-110.
23. Cohen JS, Novak GD, Li ZL. The role of mitomycin treatment duration and previous intraocular surgery on the success of trabeculectomy surgery. J Glaucoma 1997;6:3-9.
24. Mietz H, Addicks K, Bloch W, Krieglstein GK. Long-term intraocular toxic effects of topical mitomycin C in rabbits. J Glaucoma 1996;5:325-333.
25. Robin AL, Ramakrishnan R, Krishnadas R, et al. A long-term dose-response study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol 1997;115:969-974.